Related Experiment Video
Updated: May 6, 2026

Intraductal Injection of LPS as a Mouse Model of Mastitis: Signaling Visualized via an NF-κB Reporter Transgenic
Published on: September 4, 2012
Lysozyme/Tracheal Antimicrobial Peptide-Based Tissue-Specific Expression Antimicrobial Plasmids Show Broad-Spectrum
Yi Yang1,2, Yining Meng1, Daijie Chen3
1Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, 225009, China.
Abstract:
The use of antibiotics is the preferred therapy for bacterial diseases. However, overusing antibiotics has led to the development of antibiotic resistance in bacteria, which is now a major public health concern. Therefore, in this study, the performance of lysozyme (LYZ)/tracheal antimicrobial peptide (TAP)-based tissue-specific expression antimicrobial plasmids (TSEAP) have been evaluated in the treatment of mastitis in mice. The results show that LYZ/ and TAP-based TSEAP could effectively reduce the clinical symptoms caused by Staphylococcus sciuri, Bacillus cereus, Escherichia coli, and Pseudomonas aeruginosa-induced mastitis. In addition, the studies of behavioral tests, parameters of weight growth, blood biochemistry, and organ coefficients comprehensively indicate that the transfection of LYZ/TAP-based TSEAP is safe in mice. Taken together, LYZ/TAP-based TSEAP have broad-spectrum antibacterial activity and may provide new insight for the non-antibiotic treatment of bacterial diseases.
Insights
Lysozyme (LYZ)/tracheal antimicrobial peptide (TAP)-based tissue-specific expression antimicrobial plasmids (TSEAP) show broad-spectrum antibacterial activity. These novel non-antibiotic treatments effectively reduced mastitis symptoms in mice and were found to be safe.
Area of Science:
- Microbiology
- Biotechnology
- Veterinary Medicine
Background:
- Antibiotic resistance is a significant global health threat, necessitating alternative treatments for bacterial infections.
- Mastitis, a common bacterial disease, requires effective and safe therapeutic strategies.
Purpose of the Study:
- To evaluate the efficacy and safety of lysozyme (LYZ)/tracheal antimicrobial peptide (TAP)-based tissue-specific expression antimicrobial plasmids (TSEAP) for mastitis treatment.
- To explore TSEAP as a potential non-antibiotic alternative for bacterial diseases.
Main Methods:
- TSEAP constructs incorporating LYZ and TAP were designed and tested in a mouse model of mastitis.
- Infection was induced using Staphylococcus sciuri, Bacillus cereus, Escherichia coli, and Pseudomonas aeruginosa.
- Safety was assessed through behavioral tests, weight monitoring, blood biochemistry, and organ coefficient analysis.
Main Results:
- LYZ/TAP-based TSEAP significantly reduced clinical mastitis symptoms caused by the tested bacterial pathogens.
- Comprehensive safety evaluations, including behavioral, physiological, and biochemical parameters, indicated no adverse effects from LYZ/TAP-based TSEAP transfection.
- The study demonstrated the broad-spectrum antibacterial activity of LYZ/TAP-based TSEAP.
Conclusions:
- LYZ/TAP-based TSEAP represent a promising non-antibiotic therapeutic approach for bacterial diseases, including mastitis.
- These findings offer new insights into developing safe and effective antimicrobial strategies to combat antibiotic resistance.
More Related Videos
07:43A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
Published on: September 28, 2016
05:40Preparation of Agar Bead Embedded Mycobacterium abscessus to Inoculate Immunocompetent Mice Intratracheally
Published on: April 25, 2025
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Biological Methods for Microbial Control
Gene Regulation in Microbial Communities: Quorum Sensing
Inhibitors of Gram-positive Cell Wall Synthesis
Clinical Significance of Antibiotic Resistance